TOK-8801
Product Specifications
UNSPSC Description
TOK-8801 is a synthesized dihydroimidazothiazole carboxamide and is under development as an immunomodulator.
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/TOK-8801.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=C(C)N2C(S1)=NC(C)(C)C2)NCCC3=CC=CC=C3
Molecular Weight
315.43
References & Citations
[1]Fujiwara M, et al. Immunomodulatory activity of the newly synthesized compound TOK-8801 (N-(2-phenylethyl)-3,6,6-trimethyl-5,6-dihydroimidazo[2,1-b]thiazole-2- carboxamide). Jpn J Pharmacol. 1989 Dec;51(4):549-54.|[2]Shibata K, et al. Immunomodulatory effect of a newly synthesized compound, TOK-8801 (N-(2-phenylethyl)-3,6,6-trimethyl-5,6-dihydroimidazo [2,1-b]thiazole-2-carboxamide) on antibody production in vivo and delayed-type hypersensitivity in mice. Int J Immunopharmacol. 1990;12(5):497-502.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-100162/TOK-8801-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-100162/
Clinical Information
No Development Reported
CAS Number
105963-46-0
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6365297-01 0.2 mL
ZFYVE28, CT (ZFYVE28, KIAA1643, LST2, Lateral signaling target protein 2 homolog, Zinc finger FYVE domain-containing protein 28) (Azide free) (HRP)
Ask
View Details 
MBS6365297-02 5x 0.2 mL
ZFYVE28, CT (ZFYVE28, KIAA1643, LST2, Lateral signaling target protein 2 homolog, Zinc finger FYVE domain-containing protein 28) (Azide free) (HRP)
Ask
View Details 